Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Aclarion, Inc. - Common Stock (NQ: ACON )

0.0404 -0.0554 (-57.83%)
Streaming Delayed Price Updated: 9:53 AM EST, Jan 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 44,546,769
Open 0.0461
Bid (Size) 0.0400 (539)
Ask (Size) 0.0404 (108)
Prev. Close 0.0958
Today's Range 0.0330 - 0.0461
52wk Range 0.0953 - 3.850
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Dow Jumps 600 Points; US Inflation Increases To 2.9% In December
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Aclarion Announces Pricing of $14.4 Million Public Offering of Common Stock and Warrants
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory

Performance

YTD
-71.55%
-71.55%
1 Month
-60.97%
-60.97%
3 Month
-76.00%
-76.00%
6 Month
-86.58%
-86.58%
1 Year
-98.72%
-98.72%

More News

Read More
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Smart Share Global Shares Are Trading Higher By 44%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Aclarion Announces Pricing of $14.4 Million Public Offering of Common Stock and Warrants
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
Stock Indices Finished Holiday-Shortened Week With A Bullish Rally; Two New Swing Positions
Via Talk Markets
Topics ETFs Stocks / Equities
Aclarion Announces Pricing of Registered Direct Offering of Common Stock Priced at the Market
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Aclarion Announces Pricing of Registered Direct Offering of Common Stock Priced at the Market
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st
Via ACCESSWIRE
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes
Via NewMediaWire
Topics Artificial Intelligence
Exposures Artificial Intelligence
Aclarion Provides Corporate Update on Nociscan AI Technology Milestones
Via NewMediaWire
Topics Artificial Intelligence
Exposures Artificial Intelligence
Aclarion, Inc.’s (NASDAQ: ACON) Emerging Role in the Back Pain Management Sector
Via AB Newswire
Aclarion, Inc.’s (NASDAQ: ACON) Emerging Role in the Back Pain Management Sector
Via News Direct
Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial
Via NewMediaWire
Aclarion Launches Surgeon Partnership to Apply Nociscan's AI Technology to Personal Injury and Workers Compensation Market
Via NewMediaWire
Topics Artificial Intelligence
Exposures Artificial Intelligence
Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey
Via NewMediaWire
Topics Artificial Intelligence
Exposures Artificial Intelligence
Micron To $140? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Aclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan's AI Generated Biomarker Data Changes Surgical Treatment Plans
Via NewMediaWire
Topics Artificial Intelligence
Exposures Artificial Intelligence
Aclarion to Present at August 20th Virtual Investor Summit Microcap Event
Via NewMediaWire
ACON Stock Earnings: Aclarion Beats EPS, Misses Revenue for Q2 2024
Via InvestorPlace
Aclarion Announces First Commercial Agreement in Michigan
Via NewMediaWire
Aclarion Hits Another Key Milestone by Adding Vitality - Third Major Payer to Cover Nociscan in Greater UK
Via NewMediaWire
Aclarion Achieves Milestone With Key Second Payer Coverage of Nociscan by Aviva Throughout Greater London, UK
Via NewMediaWire
Aclarion Announces Initial Payer Coverage of Nociscan by AXA Throughout Greater London, UK
Via NewMediaWire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.